GILAD OREN (President) purchased 1.6% of their position (5.50K shares) of APREA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $10.1K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 4/4/2025ACC: 0001104659-25-031991
DirectorOfficer· President
Since May 2022
+5.50K
Net shares
Net buyer
$10.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5.50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3K
Price / share
$1.87
Trade value
$5.62K
% of position
0.9%
4/3/2025
340.12K→343.12K
Common Stock
Direct
Shares
+2.50K
Price / share
$1.80
Trade value
$4.49K
% of position
0.7%
4/3/2025
343.12K→345.62K
Total
Net shares
+5.50K
Net value
$10.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/3/2025 | P · Purchase | +3K | $1.87 | $5.62K | 0.9% | 340.12K | 343.12K |
| Common Stock Direct | 4/3/2025 | P · Purchase | +2.50K | $1.80 | $4.49K | 0.7% | 343.12K | 345.62K |
| Total | +5.50K | $10.11K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.20K
Common Stock
IndirectShares owned600.00
Total
1.80K indirect1.80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.20K | Indirect |
| Common Stock | 600.00 | Indirect |
| Total | 1.80K | 1.80K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported